Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.
about
The effect of alprazolam on acoustic stapedius reflex thresholds in healthy volunteersThe role of alprazolam for the treatment of panic disorder in Australia.Comparing treatment effects of oral THC on simulated and on-the-road driving performance: testing the validity of driving simulator drug researchBehavioral and Neurophysiological Signatures of Benzodiazepine-Related Driving ImpairmentsPrevalence of alcohol and drug use in injured British Columbia drivers.The Effect of Chronic Alprazolam Intake on Memory, Attention, and Psychomotor Performance in Healthy Human Male Volunteers.Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance.Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.Benzodiazepines, opioids and driving: an overview of the experimental research.Gender differences in highway driving performance after administration of sleep medication: a review of the literature.Effects of central nervous system drugs on driving: speed variability versus standard deviation of lateral position as outcome measure of the on-the-road driving test.Impact of Expanding ELISA Screening in DUID Investigations to Include Carisoprodol/Meprobamate and Zolpidem.A process-based approach to characterizing the effect of acute alprazolam challenge on visual paired associate learning and memory in healthy older adults.Evaluation of cognitive function in healthy older subjects treated with fesoterodine.Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
P2860
Q30403745-487F7987-4D67-44C3-9BBA-180ADBF2EFFEQ34258725-8903F266-E523-43BF-9D29-C7CEC98BB41EQ35884188-F442D4CA-AEAF-4A9F-B6DA-0143944B1787Q36320094-ADB821C2-D26F-4F13-AFA8-B0773D06A192Q36707458-C47F729B-0F74-4C0A-9CC4-3A29BBF3C9B4Q37100602-403E1F43-BFEA-4624-8B3F-5A294CAA4006Q37230876-0BD6546A-A4B2-4585-B250-6147006A8812Q37830027-D13753CA-F05B-4AAA-BF29-F45DDA35EA24Q37872349-F52CE195-787F-44F5-99FB-6D3D02EA7A27Q38011236-4B9E903C-909B-4C1A-94AB-4FC6A57916D0Q38174544-15E231AE-870C-4C4A-861D-893E397E5667Q39231681-CC6A61AD-501E-4FAF-A211-07795BB2099BQ47953976-6B5C6EA7-613C-490D-8B03-7FA0D9FC79A7Q50753347-EA98FD56-9066-47C5-BB3E-3C3EF67AB871Q55004778-15E1B2BE-367F-4BC7-8BA8-D8260ED9183F
P2860
Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Cognitive, psychomotor and act ...... rmulations of alprazolam 1 mg.
@en
Cognitive, psychomotor and act ...... rmulations of alprazolam 1 mg.
@nl
type
label
Cognitive, psychomotor and act ...... rmulations of alprazolam 1 mg.
@en
Cognitive, psychomotor and act ...... rmulations of alprazolam 1 mg.
@nl
prefLabel
Cognitive, psychomotor and act ...... rmulations of alprazolam 1 mg.
@en
Cognitive, psychomotor and act ...... rmulations of alprazolam 1 mg.
@nl
P2093
P2860
P1433
P1476
Cognitive, psychomotor and act ...... rmulations of alprazolam 1 mg.
@en
P2093
Beitske E Smink
Johannes G Ramaekers
Peter van Ruitenbeek
Tim R M Leufkens
P2860
P2888
P304
P356
10.1007/S00213-006-0669-8
P577
2007-01-12T00:00:00Z